camptothecin has been researched along with Autoimmune Disease in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Frese, S; Frese-Schaper, M; Gugger, M; Monestier, M; Zbaeren, J | 1 |
Avalos-Diaz, E; Bollain-y-Goytia, JJ; Daneri-Navarro, A; Herrera-Esparza, R; RamÃrez-Sandoval, R; Vazquez-del-Mercado, M | 1 |
2 other study(ies) available for camptothecin and Autoimmune Disease
Article | Year |
---|---|
Reversal of established lupus nephritis and prolonged survival of New Zealand black x New Zealand white mice treated with the topoisomerase I inhibitor irinotecan.
Topics: Animals; Autoimmune Diseases; Camptothecin; Crosses, Genetic; DNA Topoisomerases, Type I; Enzyme Inhibitors; Female; Irinotecan; Lupus Nephritis; Mice; Mice, Inbred NZB; Proteinuria; Random Allocation; Survival Analysis; Time Factors; Topoisomerase I Inhibitors | 2010 |
Caspase 3 blocking avoids the expression of autoantigens triggered by apoptosis in neonatal Balb/c mice skin.
Topics: Amino Acid Chloromethyl Ketones; Animals; Animals, Newborn; Apoptosis; Autoantigens; Autoimmune Diseases; Biopsy; Camptothecin; Caspase Inhibitors; Cells, Cultured; Cycloheximide; Cysteine Proteinase Inhibitors; Drug Evaluation, Preclinical; Hydrogen Peroxide; In Situ Nick-End Labeling; Mercuric Chloride; Mice; Mice, Inbred BALB C; Organ Culture Techniques; Skin | 2011 |